# A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes

> **NCT02287181** · PHASE4 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 100 (actual)

## Conditions studied

- Induction of Anaesthesia

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Propofol
- **OTHER:** Bispectral index

## Key facts

- **NCT ID:** NCT02287181
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287181, "A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02287181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*